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Abstract: A library of steviol-based trifunctional chiral ligands was developed from commercially
available natural stevisoide and applied as chiral catalysts in the addition of diethylzinc to
benzaldehyde. The key intermediate steviol methyl ester was prepared according to literature
procedure. Depending on the epoxidation process, both cis- and trans-epoxyalcohols were obtained.
Subsequent oxirane ring opening with primary and secondary amines afforded 3-amino-1,2-diols.
The ring opening with sodium azide followed by a “click” reaction with alkynes resulted in
dihydroxytriazoles. The regioselective ring closure of N-substituted aminodiols with formaldehyde
was also investigated. The resulting steviol-type aminodiols were tested against a panel of human
adherent cancer cell lines (A2780, SiHa, HeLa, and MDA-MB-231). It was consistently found that the
N-benzyl substituent is an essential part within the molecule and the ring closure towards N-benzyl
substituted oxazolidine ring system increased the antiproliferative activity to a level comparable with
that of cisplatine. In addition, structure–activity relationships were examined by assessing substituent
effects on the aminodiol systems.
Keywords: aminodiol; steviol; diterpene; triazole; click reaction; chiral catalysts; antiproliferative activity
1. Introduction
In recent years, aminodiols and their N-heterocyclic analogues have proven to be important
building blocks of new chiral catalysts, or even complex bioactive molecules with significant biological
activities [1,2]. Several aminodiol-based nucleoside analogues prepared recently have been shown
to possess cardiovascular, cytostatic, and antiviral effects [3–5]. The Abbott aminodiol, found to be
a useful building block for the synthesis of the potent renin inhibitors Zankiren® and Enalkiren®,
was introduced into the therapy of hypertension [6,7]. Aminodiols can also exert antidepressive
activity. For example, (S,S)-reboxetine, a selective norepinephrine reuptake inhibitor, was approved in
many countries for the treatment of unipolar depression [8]. Other aminodiols may serve as starting
materials for the synthesis of biologically active natural compounds. For example, cytoxazone, a
microbial metabolite isolated from Streptomyces species, is a selective modulator of the secretion of TH2
cytokine [2,9].
Besides their biological interest, aminodiols have also been applied as starting materials in
asymmetric syntheses or as chiral auxiliaries and ligands in enantioselective transformations [1].
To develop new, efficient, and commercially available chiral catalysts, chiral natural products,
including (+)- and (−)-α-pinene [10,11], (−)-nopinone [12], (+)-carene [13,14], (+)-sabinol [15],
(−)-pulegone [16], or menthone [17], can serve as important starting materials for the synthesis of
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aminodiols. Monoterpene-based aminodiols have been demonstrated to be excellent chiral auxiliaries
in a wide range of stereoselective transformations, including Grignard addition [18,19], intramolecular
[2 + 2] photocycloaddition [20], and intramolecular radical cyclization [21].
Although monoterpene-based 3-amino-1,2-diols are well-known compounds, their sesquiterpene
or diterpene analogues are still not known in the literature. This is despite the fact that
dihydroxy-substituted diterpene alkaloids as formal aminodiols with diverse pharmacological activity,
owing to both basic nitrogen incorporated into their ring system and separated hydroxyl groups, have
been thoroughly studied [22,23]. From this point of view, steviol, the aglycon of natural artificial
sweetener stevisoide (isolated from the extract of the Paraguayan shrub Stevia rebaudiana L.) [24], has
proved to be excellent starting material for the synthesis of ent-kaurane diterpenoids [25], with a wide
range of biological activity (Figure 1), such as cytotoxic and apopthosis (I-III) [26–29], or glutathione
S-transferase-inducing activity [30].
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several reviews have disclosed thorough discussions about the syntheses of steviol-based polyols 
[28,32], or even more complex structures [25,33,34]. It is important to note that, in most cases, acid 
sensitivity and the rapid rearrangement of the ent-kaurane ring system were mentioned as the 
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In the present contribution, we report the preparation of a new library of steviol-based chiral 
trifunctional synthons, such as aminodiols, azidodiols, and dihydroxytriazols, starting from 
commercially available natural stevioside. Our study also involves the evaluation of the resulting 
ligands as catalysts in the asymmetric addition of Et2Zn to benzaldehyde and their antiproliferative 
activity on multiple human cancer cell lines. 
2. Results 
2.1. Synthesis of Steviol-Based Epoxyalcohol Key Intermediates 4 and 5 
Steviol (2) was prepared starting from commercially available natural stevioside (1), the 
glycoside of steviol, in two steps, according to literature methods [26,35]. The esterification of 2 was 
accomplished with diazomethane, resulting in steviol methyl ester (3) [26]. The epoxidation of 3 with 
t-BuOOH in the presence of vanadyl acetylacetonate (VO(acac)2) as the catalyst furnished cis-
epoxyalcohol 4 in a stereospecific reaction with known stereochemistry (Scheme 1) [32,36]. 
Figure 1. Examples for steviol derivatives with remarkable biological activities.
Some steviol derivatives that have substituted the carboxylic function with an amino group at
the C-4 position possess inhibitory effects against Hepatitis B virus (Figure 1, IV) [31]. In recent
years, several reviews have disclosed thorough discussions about the syntheses of steviol-based
polyols [28,32], or even more complex structures [25,33,34]. It is important to note that, in most cases,
acid sensitivity and the rapid rearrangement of the ent-kaurane ring system were mentioned as the
limitation of transformations.
In the present contribution, we report the preparation of a new library of steviol-based
chiral trifunctional synthons, such as aminodiols, azidodiols, and dihydroxytriazols, starting from
commercially available natural stevioside. Our study also involves the evaluation of the resulting
ligands as catalysts in the asymmetric addition of Et2Zn to benzaldehyde and their antiproliferative
activity on multiple human cancer cell lines.
2. Results
2.1. Synthesis of Steviol-Based Epoxyalcohol Key Intermediates 4 and 5
Steviol (2) was prepared starting from commercially available natural stevioside (1), the glycoside
of steviol, in two steps, according to literature methods [26,35]. The esterification of 2 was accomplished
with diazomethane, resulting in steviol methyl ester (3) [26]. The epoxidation of 3 with t-BuOOH in
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the presence of vanadyl acetylacetonate (VO(acac)2) as the catalyst furnished cis-epoxyalcohol 4 in a
stereospecific reaction with known stereochemistry (Scheme 1) [32,36].Int. J. Mol. Sci. 2020, 20, x FOR PEER REVIEW 3 of 20 
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72%;.(iii) VO(acac)2, 70% t-BuOOH (1.5 equ.), dry toluene, 25 °C, 12 h, 65% 
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epoxidation methods, but in most cases 4 was isolated as a single product. However, when applying 
in situ-prepared dimethyldioxirane (DMDO) as a mild epoxydation reagent, diastereoisomer 5 could 
be obtained as minor component (4:5 = 2:1 ratio, separated by preparative column chromatography, 
Scheme 2) [37]. 
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The synthesis of diastereoisomeric trans-epoxyalcohol 5 was also attempted by several epoxidation
methods, but in most cases 4 was isolated as a single product. However, when applying in situ-prepared
dimethyldioxirane (DMDO) as a mild epoxydation reagent, diastereoisomer 5 could be obtained as
minor component (4:5 = 2:1 ratio, separated by preparative column chromatography, Scheme 2) [37].
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2.2. Synthesis of Steviol-Based Dihydroxytriazoles via Azidodiol 6
The reaction of cis-epoxyalcohol 4 i i azide in the pr sence of ammonium chloride in a
mixture of EtOH/water gave zidodiol 6, from whic triazoles 7–10 and 18 were generated by a “click”
reaction with various substituted alkynes (Scheme 3) [38,39].
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2.3. Synthesis of Steviol-Based Aminodiol Derivatives
The nucleophilic addition of amines to epoxyalcohols has proved to be an efficient method for
the preparation of a highly iverse library of 3-amino-1,2-diols [14,40,41]. The opening of the oxirane
ring of 4 was accomplished with different primary and secondary amines, resulting in a library of
tridentate aminodiol derivatives (11–18) presented in Table 1. When aminodiol 11 was treated with
formaldehyde at room temperature, spiro-oxazolidine 19 was obtained in a highly regioselective
ring closure. Furthermore, an alternative triazol-type tridentate product 20 was synhesized with a
click reaction, starting from N-propargyl-substituted aminodiol 17 and 2-phenylethyl azide, while the
debenzylation of 11 by hydrogenolysis over Pd/C resulted in primary aminodiol 21 with moderate
yield (Scheme 4).
Table 1. Ring opening of 4 with primary and secondary amines according to Scheme 4.
Entry Compound R1 R2 Yield (%)
1 11 H Benzyl 67
2 12 Me Benzyl 75
3 13 H (R)-α-Methylbenzyl 52
4 14 H (S)-α-Methylbenzyl 59
5 15 H i-Pr 57
6 16 Et Et 63
7 17 H Propargyl 72
8 18 H 3,5-bis(trifluoromethyl)benzyl 32
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Diasteroisomeric primary aminodiol 23 was prepared by ring opening of trans-epoxyalcohol 5
with benzylamine, followed by hydrogenolysis of 22 over Pd/C. In contrast to the cis counterpart,
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the treatment of 22 with formaldehyde at room temperature gave an inseparable mixture of
spiro-oxazolidine 24A and 1,3-oxazine 24B in a ratio of 24A:24B = 3:1 (Scheme 5) [40].
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2.4. Application of Aminodiol Derivatives as Chiral Ligands for Catalytic Addition of Diethylzinc to
Benzaldehyde
Aminodiol derivatives 7–24 were applied as chiral catalysts in the enantioselective addition
of diethylzinc to benzaldehyde 25 to study their cat lytic effect on the formation of (S)- r
(R)-1-phenyl-1-propanol 26 and 27 (Schem 6).
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member of the prepared set. Namely, its potency determined on ovarian cancer cell line (A2780) was 
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Scheme 6. Model reaction for enantioselective catalysis.
The enantiomeric purity of the major product 1-phenyl-1-propanol enantiomer (26 or 27) was
determined by GC analysis on a Chirasil-DEX CB column using the literature methods [10,42]. Low to
moderate enantioselectivities were observed. The results obtained clearly show that all aminodiol
derivatives favoured the formation of the (R)-enantiomer, whereas triazol-type compounds had only
a weak catalytic effect on the transformation. Table 2 shows the best selected results. Aminodiol 12
afforded the best, but still moderate, ee value (ee = 52%) with an (R)-selectivity. In contrast to our
earlier results, ring closure of 11 and 22 towards oxazolidines 19 and 24, or decreasing the temperature
(0 ◦C) or changing solvent (from n-hexane to toluene), did not increase catalytic activity. All other
compounds were also examined as chiral ligands, but their selectivity was less than 10%.
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Table 2. Addition of diethylzinc to benzaldehyde, catalyzed by aminodiol derivatives.
Entry Ligand Yield a (%) ee b (%) Major Configuration c
1 11 78 23 (R)
2 12 85 52 (R)
3 17 77 33 (R)
4 18 85 31 (R)
5 19 79 30 (R)
a After silica column chromatography. b Determined using the crude product by GC analysis (Chirasil-DEX CB
column). c Determined by comparing the tR of GC analysis and optical rotations with literature data [10,42].
2.5. Antiproliferative Activity of Aminodiols
The antiproliferative properties of the prepared diterpene aminodiol analogs determined on our
cancer cell panel covered a wide range. Namely, a few of them elicited no relevant effect, while the
activities of others were comparable to those of the reference agent cisplatin (Table 3) [43]. Based on
these data, some conclusions concerning structure–activity relationships could be obtained. Since
5, 6, and 21 were ineffective, it seems that the presence of the aromatic ring—even in the case of
triazol, oxazol, or benzyl derivatives—is a requirement of the cell-growth inhibiting effect of the
compounds. Among 4-substituted triazoles (7–10), only 4-ferrocenyl derivative 8 exerted substantial
action, especially against cervical SiHa cells. Testing the set of aminodiol analogs with secondary
or tertiary amino function (11–18), it was consistently found that the N-benzyl substituent is an
essential part within the molecule. Comparing 11 and 12, it seemed to be evident that a secondary
amino function is favoured over a tertiary group. Analogs containing α-methylbenzyl (13 and 14) or
bis-(trifuoromethyl)methylbenzyl groups (18) exerted reasonable antiproliferative actions, i.e., their
approximate IC50 values were 4–8 µM. It is interesting to note that in contrast to our earlier observation
on aminodiols, N-benzyl-substituted oxazolidine 19 proved to be the most potent member of the
prepared set. Namely, its potency determined on ovarian cancer cell line (A2780) was close to that of
cisplatin, while it was substantially more effective than the reference agent on the other three cell lines
(SiHa, HeLa, and MDA-MB-231). 1-Phenylethyl-substituted triazol 20 also exerted a modest action
with IC50 values of 10–15 µM.
Diastereoisomeric N-benzyl 22 has somehow a lower cytotoxic effect than 11. Meanwhile, the
activity of the inseparable mixture of its oxazine-oxazolidine analog (24A-B) is comparable to that of
19. Interestingly, 23 exhibited some minor action against MDA-MB-231 cells at 30 µM.
Table 3. Antiproliferative activities of the tested diterpene analogs.
Compound Conc
(µM)
Growth Inhibition (%) ± SEM
Calculated IC50 (µM)
A2780 HeLa SiHa MDA-MB-231
5
10 <20 * <20 <20 <20
30 <20 <20 26.81 ± 2.02 <20
6
10 <20 <20 <20 <20
30 <20 <20 <20 <20
7
10 <20 27.07 ± 1.12 <20 <20
30 38.38 ± 2.53 34.72 ± 0.32 <20 <20
8
10 49.78 ± 1.28 43.19 ± 2.20 96.41 ± 0.41 <20
30 85.21 ± 0.53 51.98 ± 2.65 96.55 ± 0.30 52.04 ± 0.85
10.18 21.89 4.64 29.90
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Table 3. Cont.
Compound Conc
(µM)
Growth Inhibition (%) ± SEM
Calculated IC50 (µM)
A2780 HeLa SiHa MDA-MB-231
9
10 22.24 ± 1.36 <20 <20 <20
30 49.35 ± 0.58 26.80 ± 0.62 28.85 ± 0.69 34.62 ± 3.14
10
10 <20 25.61 ± 3.14 <20 <20
30 48.15 ± 0.68 28.46 ± 1.98 <20 36.30 ± 3.34
11
10 54.36 ± 3.34 37.41 ± 0.57 <20 <20
30 99.24 ± 0.16 98.58 ± 0.17 96.42 ± 0.44 98.45 ± 0.06
6.68 9.37 24.68 26.16
12
10 35.57 ± 2.31 39.90 ± 2.76 <20 <20
30 65.79 ± 3.17 52.72 ± 2.04 <20 23.77 ± 1.59
17.34 23.49
13
10 84.73 ± 0.84 60.46 ± 1.65 92.54 ± 0.77 94.09 ± 0.59
30 98.75 ± 0.17 98.81 ± 0.10 96.89 ± 0.93 98.30 ± 0.24
4.19 4.79 6.07 4.32
14
10 89.99 ± 1.16 92.25 ± 0.99 91.23 ± 0.89 97.00 ± 0.16
30 98.87 ± 0.19 98.59 ± 0.07 94.34 ± 0.62 98.27 ± 0.20
4.91 3.96 6.54 4.39
15
10 <20 <20 <20 <20
30 <20 39.18 ± 1.84 20.41 ± 2.30 <20
16
10 <20 <20 <20 <20
30 29.07 ± 1.42 27.44 ± 1.06 20.83 ± 2.29 <20
17
10 20.75 ± 0.77 <20 <20 <20
30 43.94 ± 2.99 30.21 ± 0.96 <20 26.32 ± 1.04
18
10 72.12 ± 1.13 69.15 ± 2.86 59.69 ± 1.52 97.68 ± 0.13
30 99.14 ± 0.12 98.25 ± 0.22 91.88 ± 1.34 98.26 ± 0.23
6.25 5.73 7.84 4.76
19
10 98.53 ± 0.16 98.72 ± 0.11 96.50 ± 0.32 97.56 ± 0.42
30 98.97 ± 0.09 98.87 ± 0.03 97.06 ± 0.31 98.48 ± 0.40
1.07 1.05 1.62 1.25
20
10 47.33 ± 0.91 42.91 ± 1.19 <20 <20
30 98.83 ± 0.23 98.95 ± 0.22 94.82 ± 0.05 95.81 ± 0.24
9.78 10.39 14.95 15.09
21
10 <20 <20 <20 <20
30 <20 <20 <20 <20
22
10 52.78 ± 2.29 56.41 ± 0.96 86.27 ± 1.83 83.98 ± 0.41
30 99.08 ± 0.06 99.01 ± 0.72 90.88 ± 1.03 98.09 ± 0.13
8.60 4.13 8.58 6.58
23
10 <20 23.98 ± 2.06 20.95 ± 1.64 <20
30 <20 44.56 ± 1.21 28.13 ± 0.75 89.42 ± 1.00
24
10 <20 20.53 ± 0.36 <20 <20
30 22.70 ± 0.56 28.92 ± 0.53 <20 <20
Cisplatin
10 83.57 ± 1.21 42.61 ± 2.33 88.64 ± 0.50 67.51 ± 1.01
30 95.02 ± 0.28 99.93 ± 0.26 90.18 ± 1.78 87.75 ± 1.10
1.30 12.43 7.84 3.74
* Cell growth inhibition values less than 20% were considered negligible and are not given numerically.
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3. Discussion
Starting from commercially available stevioside, a new family of diterpene-based chiral
aminodiols and triazolodiols was prepared through chiral epoxyalcohols as key intermediates via
stereoselective transformations.
The resulting aminodiols exerted remarkable antiproliferative action on a panel of human cancer
cell lines. The in vitro pharmacological studies clearly showed that the N-benzyl substituent on the
amino function is essential.
Since some of the prepared molecules proved to be more potent than anticancer agent cisplatin
used clinically, the design, synthesis, and investigation of further analogs—in particular, oxazolidine
derivatives—are suggested. Concerning the outstanding action of the most potent member (19) of
the current set of molecules, a mechanistic study to explore a probable mechanism of the action is
considered to be an additional rational opportunity.
In addition, aminodiol and aminotriol derivatives were applied as chiral catalysts in the
enantioselective addition of diethylzinc to benzaldehyde, observing moderate enantioselectivity
but significant (R) selectivity.
4. Materials and Methods
4.1. General Methods
Commercially available compounds were used as obtained from suppliers (Molar Chemicals
Ltd., Halásztelek, Hungary; Merck Ltd., Budapest, Hungary and VWR International Ltd., Debrecen,
Hungary), while applied solvents were dried according to standard procedures. Optical rotations were
measured in MeOH at 20 ◦C with a PerkinElmer 341 polarimeter (PerkinElmer Inc., Shelton, CT, USA).
Chromatographic separations and the monitoring of reactions were carried out on a Merck Kieselgel
60 (Merck Ltd., Budapest, Hungary). Elemental analyses for all prepared compounds were performed
on a PerkinElmer 2400 Elemental Analyzer (PerkinElmer Inc., Waltham, MA, USA). GC measurements
for the separation of O-acetyl derivatives of enantiomers were performed on a Chirasil-DEX CB
column (2500 × 0.25 mm I.D.) on a PerkinElmer Autosystem XL GC consisting of a flame ionization
detector (PerkinElmer Corporation, Norwalk, CT, USA) and a Turbochrom Workstation data system
(Perkin-Elmer Corp., Norwalk, CT, USA). Melting points were determined on a Kofler apparatus
(Nagema, Dresden, Germany) and were uncorrected. 1H- and 13C-NMR spectra were recorded on a
Brucker Avance DRX 500 spectrometer (500 MHz (1H) and 125 MHz (13C), δ = 0 (TMS)). Chemical
shifts are expressed in ppm (δ) relative to TMS as the internal reference. J values are given by Hz. All
1H/13C NMR, NOESY, 2D-HMBC, and 2D-HMQC spectra are found in the Supplementary materials.
4.2. Starting Materials
Steviol methyl ester 3 was prepared in a two-step synthesis according to literature methods,
starting from stevioside 1, which is available commercially from Alfa Aesar Co [26,35].
4.3. Epoxydation of Steviol Methyl Ester 3
Method A: A solution of briefly-dried t-BuOOH (extracted from its 70% H2O solution with toluene,
0.60 g, 4.6 mmol; sicc. Na2CO3) in dry toluene (10 mL) was added dropwise to a stirred pale-red
solution of 3 (1.00 g, 3.0 mmol) and VO(acac)2 (3.2 mg) in dry toluene (15 mL) at room temperature.
The red color of the solution darkened during the addition and then faded to brownish yellow. Stirring
was continued for 12 h, and then a solution of KOH (0.25 g, 4.5 mmol) in brine (25 mL) was added. The
mixture was extracted with toluene (3 × 50 mL), and the organic layer was washed with brine before it
was dried (Na2SO4), filtered, and concentrated. The resulting crude product 4 (diastereomeric purity
was checked by means 1H-NMR) was purified by flash column chromatography on silica gel with
n-hexane/EtOAc 4:1 to obtain pure 4.
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Method B: 3 (1.00 g, 3.0 mmol) was dissolved in the mixture of acetone (110 mL) and water
(140 mL). Then, oxone (44.14 g, 0.29 mol) and sodium bicarbonate (96.00 g, 1.14 mol) in three to four
portions were added to the mixture with stirring at room temperature, and the mixture was stirred for
12 h and then filtered off. The aqueous acetone filtrate was extracted with Et2O (3 × 150 mL) and the
organic phase was dried (Na2SO4) and evaporated to dryness. The resulting mixture of 4 and 5 was
purified by column chromatography on silica gel with n-hexane/EtOAc 4:1 to obtain pure 4 and 5.
4.3.1. (2’S,4R,6aS,9S,11aR,11bS)-Methyl 9-hydroxy-4,11b-dimethyldodecahydro-1H-spiro[6a,9-
methanocyclohepta[a]naphthalene-8,2’-oxirane]-4-carboxylate (4)
Yield: 0.68 g (65%, Method A), 0.44 g (43%, Method B), white crystals, m.p.: 144–146 ◦C.
[α]20D = −83.0 (c 0.190, CHCl3). All spectroscopic data of 4 were consistent with those reported in
literature [32,36].
4.3.2. (2’R,4R,6aS,9S,11aR,11bS)-Methyl9-hydroxy-4,11b-dimethyldodecahydro-1H-spiro[6a,9-
methanocyclohepta[a]naphthalene-8,2’-oxirane]-4-carboxylate (5)
Yield: 0.22 g (21%, Method B), white crystals, m.p.: 149–151 ◦C, [α]20D = –48.0 (c 0.240, CHCl3).
1H
NMR (500 MHz, CDCl3): δ 0.81–0.89 (4H, m), 0.97–1.08 (3H, m), 1.17 (3H, s), 1.43–1.97 (14H, m), 2.17
(2H, t, J = 24.4 Hz), 2.67 (1H, d, J = 5.4 Hz), 3.09 (1H, d, J = 5.3 Hz), 3.65 (3H, s). 13C NMR (125 MHz,
CDCl3): δ 15.5, 19.1, 19.5, 21.5, 28.7, 35.5, 38.0, 39.3, 40.7, 41.4, 41.7, 43.8, 45.1, 46.9, 51.2, 52.8, 53.9, 56.8,
65.6, 76.3, 178.0. Anal. calcd. for C21H32O4: C, 72.38; H, 9.26. Found: C, 72.51; H, 8.98.
4.4. (4R,6aS,8S,9S,11aR,11bS)-Methyl8-(azidomethyl)-8,9-dihydroxy-4,11b-dimethyltetradecahydro-6a,9-
methanocyclohepta[a]naphthalene-4-carboxylate (6)
NaN3 (0.11 g, 1.7 mmol) and NH4Cl (0.09 g, 1.7 mmol) were added to a stirred solution of 4 (0.30 g,
0.86 mmol) in an EtOH and water 8:1 mixture (10 mL). The solution was reflux for 6 h, then water
(20 mL) was added and the mixture was extracted with Et2O (3×20 mL). The organic phase was dried
(Na2SO4) and evaporated to dryness. The crude product was purified by column chromatography on
silica gel with EtOAc/n-hexane 9:1.
Yield: 0.19 g (57%), white crystals, m.p.: 157–160 ◦C, [α]20D = –19.0 (c 0.210, CHCl3).
1H NMR
(500 MHz, CDCl3): δ 0.77–0.82 (4H, m), 0.90 (1H, d, J = 8.7 Hz), 0.96–1.04 (2H, m), 1.16 (3H, s), 1.36–1.57
(5H, m), 1.61–1.67 (3H, m), 1.72–1.88 (7H, m), 2.18 (1H, d, J = 13.3 Hz), 3.10 (1H, s), 3.45–3.51 (2H, m),
3.63 (3H, s). 13C NMR (125 MHz, CDCl3): δ 15.3, 19.0, 20.0, 22.0, 28.6, 33.6, 38.0, 39.3, 40.7, 41.6, 41.9,
42.9, 43.8, 51.1, 52.1, 54.6, 56.4, 56.7, 77.4, 80.6, 177.8. Anal. calcd. for C21H33N3O4: C, 64.42; H, 8.50; N,
10.73. Found: C, 64.65; H, 8.74; N, 10.59.
4.5. General Procedure for the “Click” Reaction of 6 for the Preparation of 7–10
CuSO4*5H2O (2 mol%; 1.3 mg) catalyst, 10 mol% sodium ascorbate (5.2 mg), and alkyne (0.5 mmol)
in DCM (10 mL) were added at 25 ◦C to a stirred solution of 6 (0.10 g, 0.3 mmol). Stirring was continued
for 16 h at room temperature, then water (20 mL) was added and the mixture was extracted with DCM
(3 × 20 mL). The organic phase was dried (Na2SO4) and evaporated to dryness. Compounds 7–10 were
isolated after flash column chromatography on silica gel column with CHCl3/MeOH 9:1.
4.5.1. (4R,6aS,8S,9S,11aR,11bS)-Methyl
8,9-dihydroxy-4,11b-dimethyl-8-((4-phenyl-1H-1,2,3-triazol-1-yl) methyl)
tetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (7)
The reaction was accomplished with ethynylbenzene according to the general procedure. Yield:
0.11 g (83%), white crystals, m.p.: 190–193 ◦C, [α]20D = –26.0 (c 0.210, CHCl3).
1H NMR (500 MHz,
DMSO): δ 0.78–0.80 (3H, m), 0.83–0.94 (2H, m), 0.98–1.07 (2H, m), 1.10 (3H, s), 1.16 (1H, d, J = 14.8 Hz),
1.28–1.45 (3H, m), 1.58–1.83 (11H, m), 2.04 (1H, d, J = 13.2 Hz), 3.57 (3H, s), 4.21 (1H, s), 4.28 (1H, d,
J = 13.9 Hz), 4.51 (1H, d, J = 13.9 Hz), 4.80 (1H, s), 7.30–7.34 (1H, m), 7.44 (2H, t, J = 7.9 Hz), 7.83 (2H, d,
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J = 7.9, 8.2 Hz), 8.48 (1H, s).13C NMR (125 MHz, DMSO): δ 15.5, 19.1, 19.9, 22.2, 28.6, 33.6, 37.9, 39.2,
39.5, 40.4, 41.2, 42.0, 43.6, 51.3, 51.5, 54.3, 54.5, 56.2, 77.1, 79.5, 123.2, 125.5, 128.1, 129.4, 131.5, 146.1,
177.5. Anal. calcd. for C29H39N3O4: C, 70.56; H, 7.96; N, 8.51. Found: C, 70.34; H, 8.08; N, 8.11.
4.5.2. Cyclopenta-2,4-dien-1-yl(2-(1-(((4R,6aS,8S,9S,11aR,11bS)-8,9-dihydroxy-4-(methoxycarbonyl)-
4,11b-dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalen-8-yl)methyl)-1H-1,2,3-triazol-
4-yl)cyclopenta-2,4-dien-1-yl)iron (8)
The reaction was accomplished with ethynylferrocene according to the general procedure. Yield:
0.14 g (91%), yellow crystals, m.p.: 138–142 ◦C, [α]20D = –15.0 (c 0.275, CHCl3).
1H NMR (500 MHz,
DMSO): δ 0.78–0.92 (5H, m), 0.98–1.16 (6H, m), 1.25–1.30 (1H, m), 1.37–1.46 (2H, s), 1.57–1.82 (11H, m),
2.04 (1H, d, J = 12.6 Hz), 3.57 (3H, s), 4.03 (5H, s), 4.19 (1H, s), 4.23 (1H, d, J = 13.9 Hz), 4.29 (2H, s), 4.47
(1H, d, J = 13.9 Hz), 4.70 (2H, s), 4.77 (1H, s), 8.1 (1H, s). 13C NMR (125 MHz, DMSO): δ 15.5, 19.1, 19.9,
22.2, 28.6, 33.6, 37.9, 39.2, 39.6, 41.1, 41.9, 43.6, 51.3, 51.5, 54.1, 54.5, 56.2, 66.7, 66.8, 68.6, 69.7, 76.8, 77.2,
79.5, 122.5, 144.9, 177.5. Anal. calcd. for C33H43FeN3O4: C, 65.89; H, 7.20; Fe, 9.28; N, 6.99. Found: C,
66.03; H, 7.35; Fe, 9.02; N, 6.79.
4.5.3. (4R,6aS,8S,9S,11aR,11bS)-Methyl
8,9-dihydroxy-4,11b-dimethyl-8-((4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl) methyl)
tetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (9)
Yield: 0.11 g (89%), white crystals, m.p.: 218–220 ◦C, [α]20D = –9.0 (c 0.195, CHCl3).
1H NMR
(500 MHz, CDCl3): δ 0.82–0.86 (4H, m), 0.99–1.05 (3H, m), 1.16 (3H, s), 1.35–1.47 (2H, m), 1.59–1.96
(12H, m), 2.10–2.12 (1H, m), 2.19 (1H, d, J = 13.7 Hz), 3.64 (3H, s), 4.53 (2H, dd, J = 14.0, 26.2 Hz),
7.36–7.38 (1H, m), 8.05 (1H, s), 8.19 (1H, d, J = 7.6 Hz), 8.55 (1H, d, J = 2.8 Hz), 9.00 (1H, s). 13C NMR
(125 MHz, CDCl3): δ 15.3, 19.0, 19.8, 22.0, 28.6, 33.5, 38.0, 39.3, 40.7, 41.4, 41.8, 43.4, 43.8, 51.1, 52.1, 54.5,
54.5, 56.7, 77.1, 80.3, 122.7, 123.9, 126.9, 133.2, 144.2, 146.7, 148.8, 177.8. Anal. calcd. for C28H38N4O4: C,
67.99; H, 7.74; N, 11.33. Found: C, 68.32; H, 7.56; N, 11.05.
4.5.4. (4R,6aS,8S,9S,11aR,11bS)-Methyl8-((4-cyclopropyl-1H-1,2,3-triazol-1-yl)methyl)-8,9-
dihydroxy-4,11b-dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (10)
Yield: 0.09 g (74%), colourless oil, [α]20D = +5.0 (c 0.240, CDCl3).
1H NMR (500 MHz, CHCl3): δ
0.80–0.84 (6H, m), 0.94–1.04 (5H, m), 1.16 (3H, s), 1.33–1.46 (2H, m), 1.58–1.95 (13H, m), 2.09–2.11 (1H,
m), 2.17 (1H, d, J = 13.5 Hz), 3.63 (3H, s), 4.32 (1H, d, J = 13.8 Hz), 4.45 (1H, d, J = 13.8 Hz), 7.40 (1H, s).
13C NMR (125 MHz, CDCl3): δ 6.6, 7.9, 7.9, 15.3, 19.0, 19.8, 22.0, 28.6, 33.4, 38.0, 39.3, 40.6, 41.2, 41.8,
43.2, 43.7, 51.2, 52.1, 54.2, 54.5, 56.7, 77.1, 80.2, 122.7, 149.8, 177.9. Anal. calcd. for C26H39N3O4: C,
68.24; H, 8.59; N, 9.18. Found: C, 68.63; H, 8.52; N, 8.86.
4.6. General Procedure for the Preparation of 11–18
LiClO4 (91.5 mg, 0.9 mmol) and the appropriate amine (0.9 mmol) were added to a solution of 4
(150.0 mg, 0.4 mmol) in MeCN (10 mL). The solution was stirred for three days at room temperature,
then water (20 mL) was added and the mixture was extracted with Et2O (3 × 15 mL). The organic
phase was dried (Na2SO4) and evaporated to dryness. The crude product was purified by column
chromatography on silica gel with MeOH/CHCl3 1:9.
4.6.1. (4R,6aS,8S,9S,11aR,11bS)-Methyl
8-((benzylamino)methyl)-8,9-dihydroxy-4,11b-dimethyltetradecahydro-6a,9-methanocyclohepta
[a]naphthalene-4-carboxylate (11)
The reaction was accomplished with benzylamine according to the general procedure. Yield:
0.13 g (67%), white crystals, m.p.: 91–93 ◦C, [α]20D = –15.0 (c 0.250, CDCl3).
1H NMR (500 MHz, CHCl3):
δ 0.74–0.79 (1H, m), 0.81 (3H, s), 0.85 (1H, d, J = 8.5 Hz), 0.94–1.02 (2H, m), 1.15 (3H, s), 1.32–1.56 (5H,
m), 1.60–1.74 (6H, m), 1.78–1.86 (4H, m), 2.16 (1H, d, J = 13.3 Hz), 2.77–2.82 (2H, m), 3.62 (3H, s), 3.81
(2H, dd, J = 13.2, 31.0 Hz), 7.25–7.34 (5H, m). 13C NMR (125 MHz, CDCl3): δ 15.3, 19.0, 19.8, 22.0, 28.6,
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33.2, 38.1, 39.3, 40.7, 41.6, 42.0, 43.4, 43.8, 51.1, 52.3, 53.3, 53.9, 54.7, 56.8, 76.4, 80.6, 127.4, 128.3, 128.6,
138.9, 177.9. Anal. calcd. for C28H41NO4: C, 73.81; H, 9.07; N, 3.07. Found: C, 74.01; H, 9.25; N, 3.02.
4.6.2. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8-((benzyl(methyl)amino)methyl)-8,9-dihydroxy-4,11b-
dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (12)
The reaction was accomplished with N-benzylmethylamine according to the general procedure.
Yield: 0.15 g (75%), white crystals, m.p.: 96–98 ◦C, [α]20D = –26.0 (c 0.240, CHCl3).
1H NMR (500 MHz,
CDCl3): δ 0.76–0.88 (5H, m), 0.92–1.03 (2H, m), 1.15 (3H, s), 1.33–1.93 (15H, m), 2,17 (1H, d, J = 13.0 Hz),
2.23 (3H, s), 2.44 (1H, d, J = 12.5 Hz), 2.79 (1H, d, J = 12.4 Hz), 3.54 (1H, d, J = 13.0 Hz), 3.63 (1H, s), 3.71
(1H, d, J = 12.9 Hz), 7.25–7.34 (5H, m). 13C NMR (125 MHz, CDCl3): δ 15.4, 19.0, 20.0, 22.1, 28.7, 31.2,
38.1, 39.2, 40.7, 41.4, 42.1, 42.6, 43.8, 43.9, 51.1, 54.7, 56.8, 57.1, 60.4, 63.0, 74.9, 79.7, 127.4, 128.4, 129.0,
138.1, 177.9. Anal. calcd. for C29H43NO4: C, 74.16; H, 9.23; N, 2.98. Found: C, 74.41; H, 9.35; N, 2.82.
4.6.3. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8,9-dihydroxy-4,11b-dimethyl-8-((((R)-1-phenylethyl)amino)
methyl) tetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (13)
The reaction was accomplished with (R)-α-methylbenzylamine according to the general procedure.
Yield: 0.11 g (52%), white crystals, m.p.: 131–133 ◦C, [α]20D = –78.0 (c 0.263, CHCl3).
1H NMR (500 MHz,
CDCl3): δ 0.69–0.78 (5H, m), 0.92–0.99 (2H, m), 1.14 (3H, s), 1.26–1.41 (8H, m), 1.54–1.83 (10H, m), 2.15
(1H, d, J = 13.3 Hz), 2.60 (2H, dd, J = 12.0, 37.7 Hz), 3.61 (3H, s), 3.66 (2H, dd, J = 6.6, 13.3 Hz), 7.22–7.33
(5H, m). 13C NMR (125 MHz, CDCl3): δ 15.2, 19.0, 19.7, 22.0, 23.9, 28.6, 33.1, 38.0, 39.2, 40.6, 41.6, 42.0,
43.3, 43.8, 51.0, 51.1, 53.2, 54.7, 56.8, 58.6, 76.5, 80.6, 126.6, 127.2, 128.5, 144.7, 177.9. Anal. calcd. for
C29H43NO4: C, 74.16; H, 9.23; N, 2.98. Found: C, 74.45; H, 9.50; N, 2.79.
4.6.4. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8,9-dihydroxy-4,11b-dimethyl-8-((((S)-1-phenylethyl)amino)
methyl) tetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (14)
The reaction was accomplished with (S)-α-methylbenzylamine according to the general procedure.
Yield: 0.12 g (59%), white crystals, m.p.: 111–112 ◦C, [α]20D = +8 (c 0.263, CHCl3).
1H NMR (500 MHz,
CDCl3): δ 0.74–0.84 (5H, m), 0.94–1.01 (2H, m), 1.14 (3H, s), 1.26–1.43 (8H, m), 1.57–1.87 (10H, m), 2.16
(1H, d, J = 13.3 Hz), 2.58 (1H, d, J = 12.0 Hz), 2.71 (1H, d, J = 12.0 Hz), 3.63 (3H, s), 3.77 (1H, dd, J = 6.6,
13.2 Hz), 7.23–7.34 (5H, m). 13C NMR (125 MHz, CDCl3): δ 15.3, 19.0, 19.8, 22.0, 23.8, 28.6, 29.7, 33.3,
38.1, 39.3, 40.7, 41.5, 42.0, 43.5, 43.8, 51.0, 51.1, 53.1, 54.7, 56.8, 58.5, 76.4, 80.6, 126.5, 127.2, 128.6, 177.9.
Anal. calcd. for C29H43NO4: C, 74.16; H, 9.23; N, 2.98. Found: 74.47; H, 9.47; N, 2.88.
4.6.5. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8,9-dihydroxy-8-((isopropylamino)methyl)-4,11b-
dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (15)
The reaction was accomplished with isopropylamine according to the general procedure. Yield:
0.10 g (57%), white crystals, m.p.: 231–235 ◦C, [α]20D = –27 (c 0.254, CDCl3).
1H NMR (500 MHz, CDCl3):
δ 0.78–0.81 (4H, m), 0.91–1.02 (3H, m), 1.15 (3H, s), 1.25–1.29 (1H, m), 1.33–1.50 (9H, m), 1.59–1.86 (11H,
m), 2.17 (1H, d, J = 13.0 Hz), 3.07 (1H, d, J = 12.6 Hz), 3.18 (1H, d, J = 12.6 Hz), 3.48–3,51 (1H, m), 3.64
(3H, s). 13C NMR (125 MHz, CDCl3): δ 15.4, 18.8, 19.0, 19.2, 19.8, 22.0, 28.7, 32.7, 38.0, 39.2, 40.6, 41.3,
41.9, 43.0, 43.7, 47.3, 50.8, 51.2, 53.2, 54.4, 56.7, 75.3, 80.5, 177.9. Anal. calcd. for C24H41NO4: C, 70.72;
H, 10.14; N, 3.44. Found: C, 70.94; H, 10.01; N, 3.81.
4.6.6. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8-((diethylamino)methyl)-8,9-dihydroxy-4,11b-
dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate hydrochloride (16)
The reaction was accomplished with diethylamine according to the general procedure. Yield: 0.11
g (63%), white crystals, m.p.: 183–185 ◦C, [α]20D = –17 (c 0.240, CHCl3).
1H NMR (500 MHz, DMSO): δ
0.75–0.81 (4H, m), 0.88 (1H, s), 0.98–1.07 (2H, m), 1.11 (3H, s), 1.21–1.23 (6H, m), 1.30–1.23 (2H, m),
1.53–1.77 (13H, m), 2.04 (1H, d, J = 12.6 Hz), 3.07–3.21 (6H, m), 3.57 (3H, s), 4.51 (1H, s), 5.09 (1H, s),
9.17 (1H, s). 13C NMR (125 MHz, DMSO): δ 8.8, 9.0, 15.4, 19.1, 19.8, 22.2, 28.6, 33.1, 37.9, 39.1, 40.4, 41.7,
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41.9, 42.4, 43.6, 46.8, 48.4, 51.5, 53.7, 54.2, 55.5, 56.2, 75.0, 80.3, 177.5. Anal. calcd. for C25H44ClNO4: C,
65.55; H, 9.68; Cl, 7.74; N, 3.06. Found: C, 65.73; H, 9.49; Cl, 7.96; N, 3.11.
4.6.7. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8,9-dihydroxy-4,11b-dimethyl-8-((prop-2-yn-1-ylamino)
methyl) tetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (17)
The reaction was accomplished with propargylamine according to the general procedure. Yield:
0.13 g (72%), white crystals, m.p.: 123–124 ◦C, [α]20D = –32 (c 0.250, CHCl3).
1H NMR (500 MHz, CDCl3):
δ 0.77–0.83 (4H, m), 0.90 (1H, d, J = 8.6 Hz), 0.95–1.04 (2H, m), 1.16 (3H, s), 1.35–1.45 (3H, m), 1.61–1.89
(12H, m), 2.17 (1H, d, J = 11.0 Hz), 2.25 (1H, m), 2.89 (2H, dd, J = 12.0, 23.2 Hz), 3.46 (2H, dd, J = 17.1,
35.7 Hz), 3.63 (3H, s). 13C NMR (125 MHz, CDCl3): δ 15.3, 19.0, 19.8, 22.0, 28.6, 33.1, 38.1, 38.3, 39.3, 40.7,
41.6, 42.0, 43.4, 43.8, 51.1, 52.0, 53.3, 54.7, 56.8, 72.2, 76.4, 80.6, 80.94, 177.9. Anal. calcd. for C24H37NO4:
C, 71.43; H, 9.24; N, 3.47. Found: C, 71.69; H, 9.47; N, 3.28.
4.6.8. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8-(((3,5-bis(trifluoromethyl)benzyl)amino)methyl)-8,9-
dihydroxy-4,11b-dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (18)
The reaction was accomplished with 3,5-bis(trifluoromethyl)benzylamine according to the general
procedure. Yield: 0.08 g (32%), white crystals, m.p.: 173–176 ◦C, [α]20D = –38 (c 0.370, CHCl3).
1H NMR
(500 MHz, CDCl3): δ 0.75–0.79 (1H, m), 0.82 (3H, s), 0.86–0.88 (1H, m), 0.95–1.03 (2H, m), 1.15 (3H, s),
1.34–1.57 (5H, m), 1.63–1.89 (10H, m), 2.79 (2H, dd, J =11.8, 35.3 Hz), 3.63 (3H, s), 3.90–3.96 (2H, m),
7.78–7.79 (3H, m). 13C NMR (125 MHz, CDCl3): δ 15.3, 19.0, 19.8, 22.0, 28.6, 33.2, 38.0, 39.2, 40.6, 41.5,
42.0, 43.4, 43.7, 51.1, 52.8, 53.1, 53.2, 54.6, 56.7, 76.6, 80.6, 121.3, 122.2, 124.4, 128.2, 131.8 (2 CF3, dd,
J = 33.2, 66.4 Hz), 142.3, 177.9. Anal. calcd. for C30H39F6NO4: C, 60.90; H, 6.64; N, 2.37. Found: C,
61.11; H, 6.89; N, 2.12.
4.6.9. (4R,6aS,8R,9S,11aR,11bS)-Methyl 8-((benzylamino)methyl)-8,9-dihydroxy-4,11b-
dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (22)
The reaction was accomplished starting from epoxyalcohol 5 (0.12 g, 0.3 mmol), MeCN (10 mL),
LiClO4 (70.2 mg, 0.7 mmol), and benzylamine (70.7 mg, 0.7 mmol) according to the general procedure.
Yield: 0.12 g (77%), white crystals, m.p.: 97–99 ◦C, [α]20D = –31 (c 0.164, CHCl3).
1H NMR (500 MHz,
CDCl3): δ 0.78–0.85 (4H, m), 0.93–1.03 (3H, m), 1.15 (3H, s), 1.28–1.52 (7H, m), 1.68–1.98 (8H, m), 2.17
(1H, d, J = 14.0 Hz), 2.58 (1H, d, J = 12.0 Hz), 3.02 (1H, d, J = 12.0 Hz), 3.62 (3H, s), 3.76–3.82 (2H, m),
7.24–7.34 (5H, m). 13C NMR (125 MHz, CDCl3): δ 15.2, 19.1, 20.1, 21.6, 28.7, 35.7, 38.1, 39.3, 40.6, 41.2,
42.1, 43.8, 44.8, 51.1, 53.8, 54.7, 54.8, 56.9, 57.8, 76.3, 82.4, 127.2, 128.2, 128.5, 139.3, 177.9. Anal. calcd.
for C28H41NO4: C, 73.81; H, 9.07; N, 3.07. Found: C, 74.03; H, 9.29; N, 2.95.
4.7. General Procedure for Ring Closure of 11 and 22 with Formaldehyde
Aqueous formaldehyde (35%; 5 mL) was added to a solution of aminodiol 11 or 22 (0.10 g,
0.2 mmol) in Et2O (5 mL) and the mixture was stirred at room temperature. After 1 h of stirring, the
mixture was made alkaline with 10% aqueous KOH (10 mL) and extracted with Et2O (3 × 50 mL). After
drying (Na2SO4) and solvent evaporation, crude products 19 and 24 were purified by recrystallization
from DCM.
4.7.1. (4R,5’S,6aS,9S,11aR,11bS)-Methyl3’-benzyl-9-hydroxy-4,11b-dimethyldodecahydro-1H-
spiro[6a,9-methanocyclohepta[a]naphthalene-8,5’-oxazolidine]-4-carboxylate (19)
Yield: 0.09 g (91%), white crystals, m.p.: 106–107 ◦C, [α]20D = –44 (c 0.254, CHCl3).
1H NMR
(500 MHz, CDCl3): δ 0.75–0.80 (1H, m), 0.82 (3H, s), 0.84–0.86 (1H, m), 0.95–1.03 (2H, m), 1.16 (3H,
s), 1.32–1.49 (4H, m), 1.53–1.91 (10H, m), 2.03 (1H, d, J = 14.0 Hz), 2.17 (1H, d, J = 13.3 Hz), 2.72 (1H,
s), 2.93 (2H, dd, J = 11.2, 31.0 Hz), 3.63 (3H, s), 3.70–3.75 (2H, s), 4.25 (1H, d, J = 4.9 Hz), 4.46 (1H, d,
J = 4.9 Hz), 7.24–7.36 (5H, m). 13C NMR (125 MHz, CDCl3): δ 15.4, 19.1, 19.9, 22.0, 28.7, 32.5, 38.1, 39.2,
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40.7, 41.4, 41.8, 43.8, 45.4, 51.1, 54.3, 56.9, 57.0, 57.2, 58.2, 79.5, 86.4, 86.5, 127.3, 128.4, 128.7, 138.7, 177.8.
Anal. calcd. for C29H41NO4: C, 74.48; H, 8.84; N, 3.00. Found: C, 74.33; H, 9.06; N, 3.18.
4.7.2. (4R,5’R,6aS,9S,11aR,11bS)-Methyl3’-benzyl-9-hydroxy-4,11b-dimethyldodecahydro-1H-
spiro[6a,9-methanocyclohepta[a]naphthalene-8,5’-oxazolidine]-4-carboxylate (24A) and
(4R,6aR,7aR,11aS,13aR,13bS)-Methyl 9-benzyl-7a-hydroxy-4,13b-dimethylhexadecahydro-6a,11a-
methanonaphtho[1’,2’:5,6]cyclohepta[1,2-e][1,3]oxazine-4-carboxylate (24B)
Yield of a 3:1 mixture: 0.09 g (91%), white crystals, m.p.: 110–114 ◦C, [α]20D = –11 (c 0.234, CHCl3).
1H NMR (500 MHz, CDCl3): δ 0.82–0.89 (6H, m, minor overlapped with major), 0.95–1.05 (4H, m, minor
overlapped with major), 1.15 (3H, s, minor), 1.16 (3H, s, major), 1.32–1.58 (9H, m, minor overlapped
with major), 1.69–1.93 (12H, m, minor overlapped with major), 2.16 (1H, d, major, J = 13.7 Hz), 2.21
(1H, d, minor, J = 9.0 Hz), 2.39 (1H, d, major, J = 12.2 Hz), 2.70 (1H, s, major), 2.81 (1H, d, major,
J = 12.2 Hz), 3.45 (2H, dd, J = 15.2, 13.2 Hz), 3.62 (3H, s, minor), 3.63 (3H, s, major), 3.65–3.66 (1H, m,
major), 3.88 (1H, s, minor), 4.01 (1H, d, major, J = 8.0 Hz), 4.24 (1H, d, major, J = 8.0 Hz), 4.51 (1H, d,
minor, J = 1.7 Hz), 7.25–7.33 (5H, m, minor overlapped with major). 13C NMR (125 MHz, CDCl3): δ
15.3, 19.0, 21.6, 28.7, 33.9, 37.5, 38.0, 39.2, 40.6, 41.0, 41.9, 42.5, 43.8, 50.6, 51.1, 51.8, 55.8, 56.0, 56.8 (CH3,
major), 56.9 (CH3, minor), 57.1, 62.9, 71.9, 79.2, 82.8, 85.6, 127.4, 128.5, 128.6, 128.9, 137.1, 177.9. Anal.
calcd. for C29H41NO4: C, 74.48; H, 8.84; N, 3.00. Found: C, 74.54; H, 8.85; N, 3.01.
4.7.3. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8,9-dihydroxy-4,11b-dimethyl-8-((((1-phenethyl-1H-1,2,3-
triazol-4-yl)methyl)amino)methyl)tetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-
carboxylate (20)
CuSO4*5H2O (2 mol%; 1.8 mg) catalyst, 10 mol% sodium ascorbate (7.3 mg), and
2-(azidoethyl)benzene (0.11 g, 0.7 mmol) were added to a solution of 17 aminodiol (0.15 g, 0.4 mmol) in
DCM (15 mL). The mixture was stirred for 6 h at room temperature. Upon completion of the reaction
(indicated by TLC), the mixture was extracted with CH2Cl2 and water (3 × 20 mL). The combined
organic phase was dried (Na2SO4), filtered, and concentrated. The crude product was purified by
column chromatography on silica gel with CHCl3/MeOH 9:1.
Yield: 0.13 g (62%), white crystals, m.p.: 218–220 ◦C, [α]20D = –33 (c 0.360, CHCl3).
1H NMR
(500 MHz, CDCl3): δ 0.76–0.81 (4H, m), 0.87–0.88 (1H, m), 0.95–1.03 (2H, m), 1.15 (3H, s), 1.33–1.42 (5H,
m), 1.50–1.88 (12H, m), 2.16 (1H, d, J = 13.2 Hz), 2.80 (2H, dd, J = 12.1, 20.3 Hz), 3.20 (2H, t, J = 14.6 Hz),
3.63 (3H, s), 3.90 (2H, s), 4.58 (2H, t, J = 14.6 Hz), 7.10–7.31 (6H, m). 13C NMR (125 MHz, CDCl3): δ
15.3, 19.0, 19.8, 22.0, 28.6, 29.7, 33.1, 36.7, 38.0, 39.2, 40.6, 41.5, 42.0, 43.4, 43.8, 44.5, 51.1, 51.7, 52.3, 53.2,
54.6, 56.7, 76.5, 80.5, 122.2, 127.2, 128.7, 128.8, 137.0, 145.3, 177.9. Anal. calcd. for C33H48N4O4: C, 70.18;
H, 8.57; N, 9.92. Found: C, 70.41; H, 8.89; N, 9.77.
4.8. General Procedure for Debenzylation of 11 and 22
Aminodiol 11 or 22 (0.10 g, 0.2 mmol) in MeOH (50 mL) were added to a suspension of
palladium-on-carbon (5% Pd/C, 0.10 g) in MeOH (50 mL), and the mixture was stirred under a H2
atmosphere (1 atm) at room temperature. After completion of the reaction (as monitored by TLC, 24 h),
the mixture was filtered through a Celite pad and the solution was evaporated to dryness. The crude
products were recrystallized in Et2O, resulting in primary aminodiols 21 or 23.
4.8.1. (4R,6aS,8S,9S,11aR,11bS)-Methyl 8-(aminomethyl)-8,9-dihydroxy-4,11b-
dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (21)
Yield: 0.05 g (57%), white crystals, m.p.: 139–142 ◦C, [α]20D = –27 (c 0.225, CHCl3).
1H NMR
(500 MHz, MeOH): δ 0.76–0.80 (4H, m), 0.85–0.86 (1H, m), 0.92–1.01 (2H, m), 1.06 (3H, m), 1.19–1.79
(15H, m), 2.04 (1H, d, J = 13.1 Hz), 2.69 (2H, dd, J = 13.1, 27.1 Hz), 3.53 (3H, s). 13C NMR (125 MHz,
MeOH): δ 16.2, 20.3, 20.9, 23.3, 29.2, 34.4, 39.2, 40.6, 41.9, 42.6, 43.3, 44.5, 45.1, 46.0, 51.8, 52.9, 56.1, 58.1,
78.6, 81.1, 179.7. Anal. calcd. for C21H35NO4: C, 69.01; H, 9.65; N, 3.83. Found: C, 69.25; H, 9.37;
N, 4.03.
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4.8.2. (4R,6aS,8R,9S,11aR,11bS)-Methyl 8-(aminomethyl)-8,9-dihydroxy-4,11b-
dimethyltetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate (23)
Yield: 0.04 g (58%), white crystals, m.p.: 140–143 ◦C, [α]20D = –9 (c 0.365, CHCl3).
1H NMR
(500 MHz, MeOH): δ 0.76–0.81 (4H, m), 0.86–1.03 (3H, m), 1.06 (3H, m), 1.19–1.41 (7H, m), 1.60–2.06
(9H, m), 2.65 (1H, d, J = 12.9 Hz), 3.13 (1H, d, J = 12.8 Hz), 3.53 (3H, s). 13C NMR (125 MHz, MeOH): δ
16.0, 20.3, 21.0, 22.9, 29.2, 35.9, 39.1, 40.6, 41.9, 43.1, 43.1, 45.1, 45.5, 49.1, 51.9, 54.7, 56.2, 58.1, 76.2, 83.3,
178.3. Anal. calcd. for C21H35NO4: C, 69.01; H, 9.65; N, 3.83 Found: C, 69.25; H, 9.44; N, 4.08.
4.9. General Procedure for the Reaction of Benzaldehyde with Diethylzinc in the Presence of Chiral Catalysts
To the respective catalyst (0.1 mmol), 1 M Et2Zn in n-hexane solution (3 mL, 3.0 mmol) was
added under an argon atmosphere at room temperature. The solution was stirred for 25 min at room
temperature, and then benzaldehyde (1 mmol) was added. After stirring at room temperature for
a further 20 h, the reaction was quenched with saturated NH4Cl solution (15 mL), and the mixture
was extracted with EtOAc (2 × 20 mL). The combined organic phase was washed with H2O (10 mL),
dried (Na2SO4), and evaporated under vacuum. The crude secondary alcohols obtained were purified
by flash column chromatography (n-hexane/EtOAc 4:1). The ee and absolute configuration of the
resulting material were determined by chiral GC on a Chirasil-DEX CB column after O-acetylation in
Ac2O/DMPA/pyridine [42].
4.10. Determination of Antiproliferative Properties
The growth-inhibitory effects of the prepared steviol-based diterpen aminodiols were determined
by a standard MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay on a panel
of human gynecological malignant cells, including MDA-MB-231 (breast cancer), Hela and SiHa
(cervical cancers), and A2780 (ovarian cancer) [43]. Cell lines were purchased from ECACC
(European Collection of Cell Cultures, Salisbury, UK) except the SiHa, which was obtained from
ATCC (American Tissue Culture Collection, Manassas, VA, USA). Cells were maintained in minimal
essential medium supplemented with 10% fetal bovine serum, 1% non-essential amino acids, and
1% penicillin-streptomycin at 37 ◦C in a humidified atmosphere containing 5% CO2. All media and
supplements for these experiments were obtained from Lonza Group Ltd. (Basel, Switzerland).
Cells were seeded into 96-well plates (5000 cells/well) and incubated with the tested compounds
at 10 µM and 30 µM under cell-culturing conditions for 72 h. Then, the MTT solution (5 mg/mL)
was added to each sample, which were incubated for a further 4 h. The medium was removed and
the precipitated formazan crystals were dissolved in DMSO during 60 min of shaking at 37 ◦C. The
absorbance was measured at 545 nm by using a microplate reader, and untreated cells were used as
controls. In the case of the most effective compounds, the assays were repeated with a set of dilutions
(0.1–30 µM) in order to determine IC50 values. Two independent experiments were performed with
five wells for each condition. Cisplatin (Ebewe GmbH, Unterach, Austria), a clinically used anticancer
agent, was used as a reference agent. Calculations were performed by means of the GraphPad Prism
5.01 software (GraphPad Software Inc., San Diego, CA, USA).
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/1/184/s1.
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Abbreviations
Et2O Diethyl ether
EtOH Ethanol
HCHO Formaldehyde
EtOAc Ethyl acetate
t-BuOOH tert-Butyl hydroperoxide
VO(acac)2 Vanadyl acetylacetonate
DCM Dichloromethane
MeCN Acetonitrile
THF Tetrahydrofuran
DMDO Dimethyldioxirane
Et2Zn Diethylzinc
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